Day: November 13

MODERATOR | David Morrow, Ph.D., Scientific Lead for Advanced Therapies, European Infrastructure for Translational Medicine (EATRIS) PANELIST | Gabriele Allegri, Vice President, Global Commercial Precision Medicine, Johnson & Johnson Innovative Medicine PANELIST | Ayah Ziyada, MSc. Ph.D. Candidate, Precision Medicine Program Manager, Center for Clinical Precision Medicine and Genomics, Hamad Medical Corporation, Qatar PANELIST | […]

MODERATOR | Invited  KEYNOTE SPEAKER | Helmy Eltoukhy, Ph.D., Co-Chief Executive Officer & Chairman of the Board, Guardant Health KEYNOTE SPEAKER | AmirAli Talasaz, PhD., Co-Chief Executive Officer & Director, Guardant Health

MODERATOR | Dan Roden, M.D., Professor, Department of Medicine & Pharmacology, Senior Vice President, Personalized Medicine, and Professor Department of Biomedical Informatics, Vanderbilt University Medical Center PANELIST | Doug Biehn, President & CEO, Octave Bioscience, Inc. PANELIST | Damon Hostin, Global Lead, Market Access, Illumina PANELIST | Brad Perkins, M.D., Chief Medical Officer, Karius Diagnostics  

PRESENTER | William S. Dalton, M.D., Ph.D., Founder & Senior Advisor, Aster Insights and Emeritus Senior Member, H. Lee Moffitt Cancer Center and Research Institute AWARDEE | George Poste, D.V.M., Ph.D., Regents’ Professor and Del E. Webb Chair in Health Innovation and Chief Scientist, Complex Adaptive Systems Initiative, Arizona State University  

Machine Learning and Artificial intelligence technologies can drive biomarker discovery and validation and more readily explore divergent effects of preventive and treatment interventions across extensive data sets. What might this mean for the future of personalized medicine and what is being done to realize that future? MODERATOR | Douglas Clark, M.D., Chief Pathologist, Life Sciences and […]

MODERATOR | Invited  KEYNOTE SPEAKER | Invited 

By detecting molecular cancer signals in blood samples of seemingly healthy patients, a new generation of early cancer detection tests promises to put more patients on the path to personalized cancer treatment, sooner, when cancer may be more effectively treated. What might this mean for the future of cancer care? Leading voices discuss. MODERATOR | Omar […]